ZBTB10 and malignant colon neoplasm: These results are consistent with previous studies in colon cancer cells showing that the miR-27a antagomir and ZBTB10 overexpression decrease expression of Sp1, Sp3 and Sp4 in RKO and SW480 cells [36].